New technique lights up where drugs go in the body, cell by cell Scripps Research scientists developed a technique that maps drug binding in individual cells throughout the body, potentially explaining side effects and guiding safer drug development.
December 22, 2025
LA JOLLA, CA When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses about the answer to this question. Traditional methods can measure the concentration of a drug in an organ like the liver, but they can't pinpoint exactly which cells the drug binds to or reveal unexpected places where the drug takes action.
Usually we have almost no idea, after a drug enters the body, how it actually interacts with its target, says Professor Li Ye, the N. Paul Whittier Endowed Chair at Scripps Research and a Howard Hughes Medical Institute investigator. It's been a black box until now.
Ye and colleagues have developed a groundbreaking imaging technique that illuminates the individual cells where drugs bind throughout an entire mouse body. In a study published today in Cell, they used their method called vCATCH to map two widely prescribed cancer drugs. The results showed that one drug binds unexpectedly in the heart and blood vessels, potentially explaining its cardiovascular risks. Using the approach to test the binding sites of new drugs, during development, could help minimize such risks.
Clinical trials show if a drug works to treat disease and establish any common side effects, but exactly what the drug is doing in every cell of the body has been inaccessible. Previous drug-tracking methods relied on either grinding up tissues for analysis or using low-resolution techniques like radioactive imaging. In both cases, researchers could only get a rough sense for which organs a drug migrated to, but not exactly which cells.
In 2022, Ye's lab debuted CATCH: a method to light up the precise cells where drugs bind across the surfaces of organs like the brain. In the new work, they scaled that approach up so that it works everywhere, including deep inside larger organs like the brain, heart and lungs.
The CATCH method works with covalent drugs, which are medications that form permanent bonds with their targets. Scientists add a tiny chemical handle to these drugs before injecting them into mice. The drugs go on to bind as they usually would, and after tissues are collected, researchers treat them with a fluorescent tag and a copper molecule that enables a fast chemical reaction adding the tag onto the drug's handle, revealing where each drug molecule ended up. This kind of highly selective click chemistry reaction, which snaps chemicals together like LEGO bricks, was developed at Scripps Research by K. Barry Sharpless, the W.M. Keck Professor of Chemistry, who won the 2022 Nobel Prize in Chemistry for the invention.
To get vCATCH working more broadly across organ systems, Ye and his colleagues had to overcome a major obstacle: proteins in tissues were soaking up the copper needed for the chemical reaction, preventing it from penetrating deep into organs. Only drug binding sites on the organs' surfaces were appearing fluorescent.
The group began pre-treating tissues with excess copper to block these binding sites, and then performing up to eight cycles of bathing the tissues in both the copper and the fluorescent tags. In most imaging methods, this kind of repetitive treatment would create background noise, as imaging agents would begin accumulating in places other than their specific binding sites. In vCATCH, it works because the chemical reactions are so incredibly selective.
Click chemistry is intrinsically highly specific and efficient, explains Ye. That allows us to fully saturate the system without causing off-target effects.
Because the imaging generates multiple terabytes of data for each mouse, the team collaborated with engineers to develop AI-based analysis pipelines that can automatically identify drug-bound cells throughout the brain and body.
To test the new approach, Ye's lab mapped the binding of two targeted cancer drugs: ibrutinib (Imbruvica), used to treat blood cancers, and afatinib (Gilotrif), prescribed for non-small cell lung cancer. The whole-body maps confirmed that afatinib spread widely through lung tissue as expected. Ibrutinib showed a more surprising pattern. This drug, known to cause irregular heartbeat and bleeding problems, binds not only to its intended targets in blood cells, but also to immune cells in the liver, heart tissue and blood vessels offering clues about its side effects.
Now researchers can look more precisely at those cells and understand why ibrutinib is binding to them, says Ye.
The applications extend far beyond these two cancer drugs. Ye's team is now using vCATCH to study whether cancer drugs selectively target tumor cells more strongly than healthy tissues, and to investigate which cell types in the brain are bound by drugs like antidepressants and antipsychotics.
This could be an incredibly valuable tool for testing late-stage drug candidates to make sure they are strongly binding their targets and don't have any unwanted binding in other organs, he says.
In addition to Ye, authors of the study, Mapping cellular targets of covalent cancer drugs in the entire mammalian body, include Zhengyuan Pang, Verina H. Leung, Cailynn C. Wang, Hanbing Shen, Logan H. Sigua, Alexandra Selke, Christopher Glynn, Melaina Yender, Senhan Xu, Peng Wu, and Benjamin F. Cravatt of Scripps; Ahmadreza Attarpour, Anthony Rinaldi, and Maged Goubran of Sunnybrook Research Institute; Maria Dolores Moya-Garzon and Jonathan Z. Long of Stanford University; and Claire Rammel and Javid J. Moslehi of University of California San Francisco.
This work was supported by funding from the National
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
13/05/2026
New Adobe Premiere Color Grading Mode Accelerated on NVIDIA GPUs
Joel Pennington May 13, 2026
0 Comments
New NVIDIA RTX-accelerated features streamlin...
13/05/2026
Grass Valley announced that dB Broadcast has delivered new IP-based outside broadcast (OB) trucks for Cloudbass, featuring Grass Valley LDX 100 Series cameras a...
13/05/2026
Ikegami will exhibit the latest additions to its wide range of broadcast production cameras, control units, viewfinders and monitors on stand 5D3-1 at Broadcast...
13/05/2026
FISE, working with the founding members of the XR Sports Alliance (XRSA), Accedo, Qualcomm Technologies, Inc. and HBS, have collaborated to develop an immersive...
13/05/2026
Canon Unveils New EOS R6 V Full-Frame EOS Camera and RF20-50mm F4 L IS USM PZ Bu...
13/05/2026
Boston Conservatory at Berklee Honors Beth Morrison and Moses Pendleton at Comme...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Creative software developer Foundry today announced the latest developments on Nuke Stage. A purpose-built application for end-to-end virtual production and in-...
13/05/2026
A definitive portrait of one of Ireland's most influential musicians
New TV documentary airs Monday 18 May on RT One and RT Player at 9.35pm
Watch the...
13/05/2026
Agentic AI is changing the way users get work done. Following the success of OpenClaw, the community is embracing new open source agentic frameworks. The latest...
13/05/2026
Reinforcement-learning agents - AI systems that learn by trial and error - can c...
12/05/2026
Beyond the Hype: A Strategic Post-Hoc Analysis of NAB 2026 If NAB Show 2026 had an underlying theme, it was a quiet, industry-wide pivot from the high-energy sp...
12/05/2026
Guntermann and Drunck (G&D), a Panoptec Technologies Group company, and CT Square, led by Chandresh Shah, have announced a joint venture to distribute G&D and V...
12/05/2026
With 30 days until the start of the FIFA World Cup 2026, Telemundo, the exclusive Spanish-language home of the tournament in the United States, has announced th...
12/05/2026
The NHL has announced the return of Stanley Pup for its third consecutive year, a 90-minute special featuring adoptable rescue dogs competing on a miniature rin...
12/05/2026
NBCUniversal presented its 2026 Upfront to advertisers at Radio City Music Hall, detailing upcoming programming across NBC, Peacock, Bravo, and Versant properti...
12/05/2026
FOX Sports has announced funding for the Fandom and Social Connection Initiative at Harvard Kennedy School's Shorenstein Center on Media, Politics, and Publ...
12/05/2026
TNDV and Live Media, both divisions of Live Media Group, supported live broadcast coverage around NCAA Final Four weekend in Indianapolis, including the March M...
12/05/2026
The European Football Alliance (EFA) has announced a content distribution agreement with Fubo Sports Network, the free ad-supported streaming TV (FAST) channel ...
12/05/2026
For the first time, Spanish-speaking fans in the U.S. will have two separate tel...
12/05/2026
CP Communications led a comprehensive spectrum management initiative on behalf of Churchill Downs during Kentucky Derby week, coordinating RF assets across the ...
12/05/2026
LiveU has announced a strategic partnership with DRONERESPONDERS, a 501(c)3 non-...
12/05/2026
Open Broadcast Systems has announced that BMC TV, a specialist in IP transport of broadcast content, has selected the Open Broadcast Systems 5G Flyaway solution...
12/05/2026
NEP Europe, part of NEP Group, has announced it will deliver broadcast solutions...
12/05/2026
Grass Valley has announced continued collaboration with Ravensbourne University ...
12/05/2026
Stats Perform has announced the launch of Opta Pulse, an AI-assisted video creation and distribution platform for leagues, rights holders, and broadcasters. The...
12/05/2026
FOX Sports has announced a collaboration with Sesame Workshop to integrate Sesame Street characters into FOX Sports' FIFA World Cup 2026 programming. Conten...
12/05/2026
To date, NHL Productions has produced 19 broadcasts with commentary in American Sign Language
NHL in ASL (American Sign Language) may be just one show, but the...
12/05/2026
Google's Brian Albert: creators, athletes, highlights, nostalgia, second-scr...
12/05/2026
A still from Past Lives by Celine Song, an official selection of the Premieres program at the 2023 Sundance Film Festival. (Courtesy of Sundance Institute | p...
12/05/2026
Spotify is where fans and artists come together, turning discovery into somethin...
12/05/2026
Features patented Marco-MMC clocking technology
Black Lion Audio's latest release combines the company's expertise in clocking with their renowned p...
12/05/2026
New Track Panel, sequencer upgrades & more
Following their recent public beta release, Reason Studios have announced the full release of Reason 14. With the...
12/05/2026
One month to go! SBS reveals expansive FIFA World Cup 2026 lineup beyond the pi...
12/05/2026
Rohde & Schwarz presents its advanced solutions for power electronics testing at...
12/05/2026
aconnic AG (ISIN: DE000A0LBKW6), Munich, has developed a modified fund raising p...
12/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/05/2026
Tyrell Corporation, specialists in high-end live sports and entertainment broadcasts, was tasked with delivering compelling broadcast coverage of premier equest...
12/05/2026
Registration is now open for IBC2026 as the global media, entertainment and technology community prepares to converge on the RAI Amsterdam from 11 14 September ...
12/05/2026
Ross Video, a global leader in live video production technology, will present its latest innovations and integrated production workflows at BroadcastAsia 2026, ...
12/05/2026
500 selected leaders from around the world across start-ups, corporates, and venture capital. Over 50bn in assets under management among attending investors, a...
New technique lights up where drugs go in the body, cell by cell Scripps Research scientists developed a technique that maps drug binding in individual cells throughout the body, potentially explaining side effects and guiding safer drug development.
